The Ensign Group, Inc. (ENSG) Institutional Ownership & Insider Trading

548 institutions reported holding The Ensign Group, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 50 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ENSGThe Ensign Group, Inc.Follow ENSG — free

Medical Care Facilities · Healthcare

—

Price chart with a free account

Market cap: 10.2B
P/E TTM: 27.5
Dividend yield: 0.1%
52-week: —
Next earnings: 3 Nov, in 10 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

548 institutions held 90.6% of the shares. Across filers that reported both quarters, shares held changed -2.8%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	548	53	-2.8%	158	61	195	84
Mar 26	565	54	-1.3%	191	52	168	43
Dec 25	556	55	-0.7%	161	65	159	23
Sep 25	493	55	+2.3%	113	46	168	33
Jun 25	486	54	+0.6%	149	54	156	42
Mar 25	474	53	+1.0%	152	41	154	54
Dec 24	486	53	-3.2%	163	45	143	39
Sep 24	463	53	+1.7%	147	67	151	25

The Ensign Group, Inc. — questions

Who owns The Ensign Group, Inc. stock?: 548 institutions reported The Ensign Group, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (10.0%), BAILLIE GIFFORD & CO (8.6%), VANGUARD PORTFOLIO MANAGEMENT LLC (4.9%).
Are The Ensign Group, Inc. insiders buying or selling?: 50 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from The Ensign Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.